Research ExplorerPublicationsComparison of latest generation transfemoral self-expandable...

Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves

Standard

Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves. / Schaefer, Andreas; Linder, Matthias; Seiffert, Moritz; Schoen, Gerhard; Deuschl, Florian; Schofer, Niklas; Schneeberger, Yvonne; Blankenberg, Stefan; Reichenspurner, Hermann; Schaefer, Ulrich; Conradi, Lenard.

In: INTERACT CARDIOV TH, Vol. 25, No. 6, 01.12.2017, p. 905-911.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schaefer, A, Linder, M, Seiffert, M, Schoen, G, Deuschl, F, Schofer, N, Schneeberger, Y, Blankenberg, S, Reichenspurner, H, Schaefer, U & Conradi, L 2017, 'Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves', INTERACT CARDIOV TH, vol. 25, no. 6, pp. 905-911. https://doi.org/10.1093/icvts/ivx194

APA

Schaefer, A., Linder, M., Seiffert, M., Schoen, G., Deuschl, F., Schofer, N., Schneeberger, Y., Blankenberg, S., Reichenspurner, H., Schaefer, U., & Conradi, L. (2017). Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves. INTERACT CARDIOV TH, 25(6), 905-911. https://doi.org/10.1093/icvts/ivx194

Vancouver

Schaefer A, Linder M, Seiffert M, Schoen G, Deuschl F, Schofer N et al. Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves. INTERACT CARDIOV TH. 2017 Dec 1;25(6):905-911. https://doi.org/10.1093/icvts/ivx194

Bibtex

@article{0947dbe442814a958e87a3c7b8c1817e,
title = "Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves",
abstract = "OBJECTIVES: We herein aimed to compare acute 30-day outcomes of latest-generation self-expandable and balloon-expandable transcatheter heart valves.METHODS: From 2012 through 2016, 104 consecutive patients (study group, 69.2% female, 81.7 ± 5.5 years, logEuroSCORE I 15.9 ± 9.3%) received transfemoral transcatheter aortic valve implantation using the Symetis ACURATE neo {\textregistered} transcatheter heart valve. A control group of patients after transfemoral transcatheter aortic valve implantation with the Edwards Sapien 3{\texttrademark} transcatheter heart valve was retrieved from our database and matched to the study group. Data were retrospectively analysed according to updated Valve Academic Research Consortium definitions.RESULTS: Device success was 94.2% (98 of 104) and 98.1% (102 of 104) in study and control groups, respectively ( P  = 0.157). All-cause 30-day mortality was 3.9 (4 of 104) vs 0.9% (1 of 104) ( P =  0.317). Resultant transvalvular peak/mean gradients and effective orifice area were 14.2 ± 5.7 vs 22.6 ± 6.8 mmHg ( P  < 0.001)/7.3 ± 2.8 vs 11.8 ± 3.5 mmHg ( P  < 0.001) and 2.0 ± 0.4 vs 1.7 ± 0.4 cm 2 ( P =  0.063). Paravalvular leakage ≥moderate was observed in 4.8% (5 of 104) and 1.9% (2 of 104) ( P =  0.257). Rate of permanent pacemaker implantation was 10.6% (11 of 104) vs 16.4% (17 of 104) ( P =  0.239).CONCLUSIONS: Next-generation self-expandable transcatheter heart valves preserve superiority in terms of post-interventional haemodynamics without presenting former drawbacks: rate of postoperative permanent pacemaker implantation and severity of residual paravalvular leakage were similar to balloon-expandable transcatheter heart valves.",
keywords = "Journal Article",
author = "Andreas Schaefer and Matthias Linder and Moritz Seiffert and Gerhard Schoen and Florian Deuschl and Niklas Schofer and Yvonne Schneeberger and Stefan Blankenberg and Hermann Reichenspurner and Ulrich Schaefer and Lenard Conradi",
year = "2017",
month = dec,
day = "1",
doi = "10.1093/icvts/ivx194",
language = "English",
volume = "25",
pages = "905--911",
journal = "INTERACT CARDIOV TH",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "6",

}

RIS

TY - JOUR

T1 - Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves

AU - Schaefer, Andreas

AU - Linder, Matthias

AU - Seiffert, Moritz

AU - Schoen, Gerhard

AU - Deuschl, Florian

AU - Schofer, Niklas

AU - Schneeberger, Yvonne

AU - Blankenberg, Stefan

AU - Reichenspurner, Hermann

AU - Schaefer, Ulrich

AU - Conradi, Lenard

PY - 2017/12/1

Y1 - 2017/12/1

N2 - OBJECTIVES: We herein aimed to compare acute 30-day outcomes of latest-generation self-expandable and balloon-expandable transcatheter heart valves.METHODS: From 2012 through 2016, 104 consecutive patients (study group, 69.2% female, 81.7 ± 5.5 years, logEuroSCORE I 15.9 ± 9.3%) received transfemoral transcatheter aortic valve implantation using the Symetis ACURATE neo ® transcatheter heart valve. A control group of patients after transfemoral transcatheter aortic valve implantation with the Edwards Sapien 3™ transcatheter heart valve was retrieved from our database and matched to the study group. Data were retrospectively analysed according to updated Valve Academic Research Consortium definitions.RESULTS: Device success was 94.2% (98 of 104) and 98.1% (102 of 104) in study and control groups, respectively ( P  = 0.157). All-cause 30-day mortality was 3.9 (4 of 104) vs 0.9% (1 of 104) ( P =  0.317). Resultant transvalvular peak/mean gradients and effective orifice area were 14.2 ± 5.7 vs 22.6 ± 6.8 mmHg ( P  < 0.001)/7.3 ± 2.8 vs 11.8 ± 3.5 mmHg ( P  < 0.001) and 2.0 ± 0.4 vs 1.7 ± 0.4 cm 2 ( P =  0.063). Paravalvular leakage ≥moderate was observed in 4.8% (5 of 104) and 1.9% (2 of 104) ( P =  0.257). Rate of permanent pacemaker implantation was 10.6% (11 of 104) vs 16.4% (17 of 104) ( P =  0.239).CONCLUSIONS: Next-generation self-expandable transcatheter heart valves preserve superiority in terms of post-interventional haemodynamics without presenting former drawbacks: rate of postoperative permanent pacemaker implantation and severity of residual paravalvular leakage were similar to balloon-expandable transcatheter heart valves.

AB - OBJECTIVES: We herein aimed to compare acute 30-day outcomes of latest-generation self-expandable and balloon-expandable transcatheter heart valves.METHODS: From 2012 through 2016, 104 consecutive patients (study group, 69.2% female, 81.7 ± 5.5 years, logEuroSCORE I 15.9 ± 9.3%) received transfemoral transcatheter aortic valve implantation using the Symetis ACURATE neo ® transcatheter heart valve. A control group of patients after transfemoral transcatheter aortic valve implantation with the Edwards Sapien 3™ transcatheter heart valve was retrieved from our database and matched to the study group. Data were retrospectively analysed according to updated Valve Academic Research Consortium definitions.RESULTS: Device success was 94.2% (98 of 104) and 98.1% (102 of 104) in study and control groups, respectively ( P  = 0.157). All-cause 30-day mortality was 3.9 (4 of 104) vs 0.9% (1 of 104) ( P =  0.317). Resultant transvalvular peak/mean gradients and effective orifice area were 14.2 ± 5.7 vs 22.6 ± 6.8 mmHg ( P  < 0.001)/7.3 ± 2.8 vs 11.8 ± 3.5 mmHg ( P  < 0.001) and 2.0 ± 0.4 vs 1.7 ± 0.4 cm 2 ( P =  0.063). Paravalvular leakage ≥moderate was observed in 4.8% (5 of 104) and 1.9% (2 of 104) ( P =  0.257). Rate of permanent pacemaker implantation was 10.6% (11 of 104) vs 16.4% (17 of 104) ( P =  0.239).CONCLUSIONS: Next-generation self-expandable transcatheter heart valves preserve superiority in terms of post-interventional haemodynamics without presenting former drawbacks: rate of postoperative permanent pacemaker implantation and severity of residual paravalvular leakage were similar to balloon-expandable transcatheter heart valves.

KW - Journal Article

U2 - 10.1093/icvts/ivx194

DO - 10.1093/icvts/ivx194

M3 - SCORING: Journal article

C2 - 28655156

VL - 25

SP - 905

EP - 911

JO - INTERACT CARDIOV TH

JF - INTERACT CARDIOV TH

SN - 1569-9293

IS - 6

ER -